VERV•benzinga•
Canaccord Genuity Maintains Buy on Verve Therapeutics, Raises Price Target to $39
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 15, 2025 by benzinga